SRSAU
Sarissa Capital Acquisition Corp. [SRSAU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SRSAU Stock Summary
In the News
SRSAU Financial details
Company Rating
Buy
Market Cap
0
Income
21.63M
Revenue
0
Book val./share
-0.32
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
2.69
Forward P/E
-
PEG
-0
P/S
-
P/B
0.26
P/C
-
P/FCF
-
Quick Ratio
6.44
Current Ratio
9.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.38
EPS next Y
-
EPS next Q
-
EPS this Y
-46570.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-51.02%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
9%
ROE
10%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.8-10.465
52W High
-
52W Low
-
RSI
-
Rel Volume
0.39
Avg Volume
662
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
SRSAU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2020-12-31 | 2021-12-31 |
|---|---|---|---|
| 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | |
| Net income per share | 0 | 1.58 | |
| Operating cash flow per share | 0 | -0.02 | |
| Free cash flow per share | 0 | -0.02 | |
| Cash per share | 0.04 | 0.02 | |
| Book value per share | 7.77 | -0.66 | |
| Tangible book value per share | -0.23 | -0.66 | |
| Share holders equity per share | 7.77 | -0.66 | |
| Interest debt per share | 0 | -0.81 | |
| Market cap | 253M | 244.75M | |
| Enterprise value | 251.9M | 244.24M | |
| P/E ratio | -2.97K | 6.18 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | 0 | -418.4 | |
| PFCF ratio | 0 | -418.4 | |
| P/B Ratio | 1.3 | -14.76 | |
| PTB ratio | 1.3 | -14.76 | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | -2.96K | 12.59 | |
| EV to operating cash flow | 0 | -417.52 | |
| EV to free cash flow | 0 | -417.52 | |
| Earnings yield | 0 | 0.16 | |
| Free cash flow yield | 0 | 0 | |
| Debt to equity | 0 | 0 | |
| Debt to assets | 0 | 0 | |
| Net debt to EBITDA | 12.89 | -0.03 | |
| Current ratio | 94.37 | 11.75 | |
| Interest coverage | 0 | 0.04 | |
| Income quality | 0 | -0.03 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 0.77 | 4.86 | |
| ROIC | 0 | 0.1 | |
| Return on tangible assets | -0.06 | 62.41 | |
| Graham Net | -0.24 | -0.67 | |
| Working capital | 1.35M | 566.63K | |
| Tangible asset value | -5.65M | -16.59M | |
| Net current asset value | -5.65M | -16.6M | |
| Invested capital | 0 | 0 | |
| Average receivables | 0 | 0 | |
| Average payables | 0 | 7.24K | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 0 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | -2.39 | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.33 | 0.88 | -0.23 | 0.49 | 0.24 | |
| Operating cash flow per share | -0.01 | -0.03 | -0.05 | -0.01 | -0.01 | |
| Free cash flow per share | -0.01 | -0.03 | -0.05 | -0.01 | -0.01 | |
| Cash per share | 0.19 | 0.16 | 0.1 | 0.01 | 0.01 | |
| Book value per share | 35.95 | -3.17 | -3.32 | -0.42 | -0.32 | |
| Tangible book value per share | 35.95 | -3.17 | -3.32 | 7.58 | 7.7 | |
| Share holders equity per share | 35.95 | -3.17 | -3.32 | -0.42 | -0.32 | |
| Interest debt per share | 0 | 0 | 0.08 | -0.25 | -0.12 | |
| Market cap | 49.6M | 49.3M | 48.95M | 247.5M | 247.25M | |
| Enterprise value | 48.65M | 48.52M | 48.44M | 247.15M | 247.09M | |
| P/E ratio | 7.46 | 2.81 | -10.75 | 5.01 | 10.24 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -890.37 | -290.43 | -180.71 | -1.5K | -1.33K | |
| PFCF ratio | -890.37 | -290.43 | -180.71 | -1.5K | -1.33K | |
| P/B Ratio | 0.28 | -3.11 | -2.95 | -23.55 | -31.37 | |
| PTB ratio | 0.28 | -3.11 | -2.95 | -23.55 | -31.37 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 29.26 | 11.08 | -65.34 | 40.67 | 84.13 | |
| EV to operating cash flow | -873.26 | -285.82 | -178.82 | -1.49K | -1.33K | |
| EV to free cash flow | -873.26 | -285.82 | -178.82 | -1.49K | -1.33K | |
| Earnings yield | 0.03 | 0.09 | -0.02 | 0.05 | 0.02 | |
| Free cash flow yield | 0 | 0 | -0.01 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.57 | -0.18 | 0.69 | -0.06 | -0.05 | |
| Current ratio | 23.37 | 181.87 | 11.75 | 4.74 | 9.16 | |
| Interest coverage | 0 | 0 | -0.87 | 0.03 | 0.05 | |
| Income quality | -0.03 | -0.04 | 0.37 | -0.03 | -0.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 16.4 | 7.9 | 4.12 | 2.16 | 1.31 | |
| ROIC | 0 | 0.01 | 0.03 | 0.04 | 0.04 | |
| Return on tangible assets | 0.01 | 4.72 | -1.79 | 0.06 | 0.03 | |
| Graham Net | -4.08 | -3.2 | -3.34 | -0.43 | -0.32 | |
| Working capital | 1.08M | 904.35K | 566.63K | 369.27K | 204.06K | |
| Tangible asset value | 179.77M | -15.84M | -16.59M | 189.49M | 192.43M | |
| Net current asset value | -20.23M | -15.86M | -16.6M | -10.54M | -7.88M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 49.31K | 61.81K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 44.98 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 2 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.01 | -0.28 | 0.07 | -1.18 | -0.77 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
SRSAU Frequently Asked Questions
What is Sarissa Capital Acquisition Corp. stock symbol ?
Sarissa Capital Acquisition Corp. is a US stock , located in Greenwich of Ct and trading under the symbol SRSAU
What is Sarissa Capital Acquisition Corp. stock quote today ?
Sarissa Capital Acquisition Corp. stock price is $- today.
Is Sarissa Capital Acquisition Corp. stock public?
Yes, Sarissa Capital Acquisition Corp. is a publicly traded company.
Company Profile
- Volume Average 662
- Headquarters Greenwich,CT,US
- IPO Date 2020-09-30
Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.
